title: Polymorphisms in candidate genes for blood pressure regulation in young men with normal or elevated screening blood pressure.
abstract: We have previously shown correlations between cardiovascular risk factors such as blood pressure (BP), sympathetic nervous system activity, lipids and insulin resistance in young men with elevated screening BP. In the present study we aimed to: (1) compare the genotype distribution and allele frequencies of 11 polymorphisms in seven candidate genes for BP regulation in healthy 21-year-old Caucasian men, between 18 men with normal and 67 men with high screening BP, and (2) evaluate the effect of these polymorphisms in candidate genes on casual BP, BP responses to mental stress or catecholamines and metabolic parameters including insulin sensitivity. There were no differences in genotype distributions or allele frequencies between the subjects with normal and those with high screening BP. Insulin sensitivity was significantly higher in GG homozygotes in the G-261A polymorphism at the alpha 2A-adrenergic receptor (alpha(2A)AR) locus compared to GA heterozygotes (p = 0.007). Subjects who were homozygous both GG in the G-261A polymorphism at the alpha(2A)AR locus and GlyGly in the Arg16Gly polymorphism at the beta2-adrenergic (beta2AR) receptor loci had significantly higher insulin sensitivity and lower catecholamine levels during mental stress than subjects with other genotypes. Subjects who were II homozygous at the angiotensin converting enzyme (ACE) locus and AA homozygous at the angiotensin type I receptor (AT1R) locus had lower BP and a better lipid profile than the rest of the group. Thus, in this explorative study, we report an association between insulin sensitivity and a polymorphism at the alpha(2A)AR locus. We suggest the presence of gene-gene interactions in the renin-angiotensin system and the sympathetic nervous system.
authors.affiliation: Department of Internal Medicine, Ullevaal University Hospital, Oslo, Norway. eigil.fossum@ioks.uio.no
authors.forename: E
authors.initials: E
authors.lastname: Fossum
authors.forename: K E
authors.initials: KE
authors.lastname: Berge
authors.forename: A
authors.initials: A
authors.lastname: Høieggen
authors.forename: A
authors.initials: A
authors.lastname: Moan
authors.forename: M
authors.initials: M
authors.lastname: Rostrup
authors.forename: S E
authors.initials: SE
authors.lastname: Kjeldsen
authors.forename: I
authors.initials: I
authors.lastname: Eide
authors.forename: K
authors.initials: K
authors.lastname: Berg
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000187:drug effects / Q000235:genetics*; D002395:Catecholamines / Q000008:administration & dosage / Q000494:pharmacology; D004252:DNA Mutational Analysis; D005787:Gene Frequency; D005838:Genotype; D015309:Glucose Clamp Technique; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000235:genetics; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D008403:Mass Screening; D011110:Polymorphism, Genetic; D012084:Renin-Angiotensin System / Q000235:genetics; D013315:Stress, Psychological / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000378:metabolism
chemical_list: D002395:Catecholamines; D007328:Insulin